Driehaus Capital Management Portfolio holdings
Driehaus Capital Management is a growth equity manager founded in 1982 by Richard Driehaus, an American investor often called the father of momentum investing. Its stock funds look for companies whose earnings growth is picking up, on the view that markets tend to misprice shares after such a turn. Richard Driehaus later founded Driehaus Mutual Funds in 1996. The firm is majority-owned by Driehaus Capital Holdings, which belongs to entities related to its late founder, and its clients include pension plans, endowments, foundations, family offices and the Driehaus mutual funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$103M |
| 2 |
Credo Technology Group
CRDO
|
+$102M |
| 3 |
Vicor
VICR
|
+$83.8M |
| 4 |
Cipher Digital
CIFR
|
+$74.9M |
| 5 |
Ceco Environmental
CECO
|
+$72.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fabrinet
FN
|
+$240M |
| 2 |
Lumentum
LITE
|
+$130M |
| 3 |
Bloom Energy
BE
|
+$118M |
| 4 |
TSMC
TSM
|
+$114M |
| 5 |
Coherent
COHR
|
+$90.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.73% |
| 2 | Technology | 23.9% |
| 3 | Industrials | 20.73% |
| 4 | Financials | 9.01% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Bright Minds Biosciences
DRUG
$231M
| $30.4M | 0.18% |
433,377
+862
| +0.2% | +$67.7K |
2025 Q4
2 quarters
|
|
177
Quanta Services
PWR
$91.6B
| $30.3M | 0.18% |
42,101
-58,472
| -58% | -$40M |
2021 Q3
19 quarters
|
|
178
Protolabs
PRLB
$1.65B
| $30.2M | 0.17% |
370,151
+1,015
| +0.3% | +$71.4K |
2025 Q4
2 quarters
|
|
179
Twilio
TWLO
$34B
| $29.3M | 0.17% |
+141,973
| New | +$25.2M |
2026 Q2
0 quarters
|
|
180
ArcBest
ARCB
$3B
| $29.1M | 0.17% |
202,589
-7,754
| -4% | -$1.01M |
2026 Q1
1 quarter
|
|
181
Allient
ALNT
$1.47B
| $29M | 0.17% |
281,659
-92,299
| -25% | -$7.12M |
2025 Q4
2 quarters
|
|
182
BlackSky Technology
BKSY
$991M
| $28.9M | 0.17% |
+1,033,578
| New | +$37.3M |
2026 Q2
0 quarters
|
|
183
Dianthus Therapeutics
DNTH
$5.03B
| $28.8M | 0.17% |
295,266
-22,046
| -7% | -$1.93M |
2026 Q1
1 quarter
|
|
184
Pan American Silver
PAAS
$16.2B
| $28.7M | 0.17% |
641,329
-211,856
| -25% | -$11.3M |
2024 Q2
8 quarters
|
|
185
American Public Education
APEI
$770M
| $28.7M | 0.17% |
534,665
+2,370
| +0.4% | +$130K |
2025 Q3
3 quarters
|
|
186
Maze Therapeutics
MAZE
$2.01B
| $28.5M | 0.17% |
954,886
+318,724
| +50% | +$8.35M |
2025 Q1
5 quarters
|
|
187
Applied Aerospace & Defense Inc
AADX
$1.6B
| $28M | 0.16% |
+1,227,730
| New | +$24.1M |
2026 Q2
0 quarters
|
|
188
Tactile Systems Technology
TCMD
$608M
| $27.9M | 0.16% |
937,783
+195,869
| +26% | +$4.92M |
2025 Q4
2 quarters
|
|
189
Woodward
WWD
$20B
| $27.5M | 0.16% |
64,731
-6,504
| -9% | -$2.47M |
2025 Q4
2 quarters
|
|
190
Lattice Semiconductor
LSCC
$17.5B
| $27.3M | 0.16% |
178,691
+1,929
| +1% | +$249K |
2026 Q1
1 quarter
|
|
191
Tandem Diabetes Care
TNDM
$1.31B
| $27M | 0.16% |
1,786,996
-517,418
| -22% | -$9.04M |
2025 Q4
2 quarters
|
|
192
Flotek Industries
FTK
$959M
| $26.7M | 0.15% |
1,136,326
+167,669
| +17% | +$3.25M |
2025 Q4
2 quarters
|
|
193
Helios Technologies
HLIO
$1.57B
| $26.7M | 0.15% |
299,426
+101,458
| +51% | +$7.79M |
2025 Q3
3 quarters
|
|
194
VSE Corp
VSEC
$5.39B
| $26.7M | 0.15% |
116,779
-392,367
| -77% | -$75.4M |
2024 Q4
6 quarters
|
|
195
Madison Air Solutions
MAIR
$12.1B
| $26.5M | 0.15% |
+679,403
| New | +$26.5M |
2026 Q2
0 quarters
|
|
196
Qnity Electronics Inc
Q
$26.5B
| $26.3M | 0.15% |
160,990
+495
| +0.3% | +$72.9K |
2026 Q1
1 quarter
|
|
197
Hemab Therapeutics
COAG
$1.84B
| $26.3M | 0.15% |
+715,791
| New | +$19.8M |
2026 Q2
0 quarters
|
|
198
BorgWarner
BWA
$10.3B
| $26.1M | 0.15% |
+392,776
| New | +$24.9M |
2026 Q2
0 quarters
|
|
199
Exelixis
EXEL
$17.3B
| $26M | 0.15% |
478,322
+141,616
| +42% | +$6.89M |
2024 Q4
6 quarters
|
|
200
Ambiq Micro
AMBQ
$1.25B
| $25.5M | 0.15% |
288,979
-91,789
| -24% | -$5.44M |
2026 Q1
1 quarter
|
|
Similar funds
Driehaus Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Driehaus Capital Management held 439 positions worth $17.3B, up 27% from $13.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Driehaus Capital Management's Q2 2026 filing shows 84 new, 139 increased, 108 reduced and 85 closed positions. Its largest new stake was Cadence Design Systems: 293,693 shares worth $110M. The largest sale was Fabrinet, an estimated $240M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.
- Driehaus Capital Management's largest Q2 2026 buy was Cadence Design Systems: 293,693 shares worth $110M.
- Driehaus Capital Management added most to Vicor in Q2 2026, an estimated $83.8M increase.
- Driehaus Capital Management's biggest Q2 2026 reduction was Fabrinet, cutting an estimated $240M.
- Driehaus Capital Management fully exited National Vision in Q2 2026, selling an estimated $89.9M.
- Driehaus Capital Management's ten largest holdings make up 16% of its $17.3B portfolio in Q2 2026.
- Driehaus Capital Management opened 84 new positions and closed 85 in Q2 2026.
- Driehaus Capital Management's portfolio value rose 27% quarter-over-quarter to $17.3B.
Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.